MENU
+Compare
UNCY
Stock ticker: NASDAQ
AS OF
Apr 11 closing price
Price
$0.55
Change
+$0.02 (+3.77%)
Capitalization
65.55M

UNCY Unicycive Therapeutics Forecast, Technical & Fundamental Analysis

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions... Show more

UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UNCY with price predictions
Apr 10, 2025

UNCY's RSI Indicator climbs out of oversold territory

The RSI Oscillator for UNCY moved out of oversold territory on April 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where UNCY advanced for three days, in of 159 cases, the price rose further within the following month. The odds of a continued upward trend are .

UNCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 88 cases where UNCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UNCY as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UNCY turned negative on March 31, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

UNCY moved below its 50-day moving average on April 04, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for UNCY crossed bearishly below the 50-day moving average on April 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UNCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UNCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.540) is normal, around the industry mean (13.237). P/E Ratio (0.000) is within average values for comparable stocks, (62.880). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.738). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (39.216) is also within normal values, averaging (246.127).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UNCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

UNCY is expected to report earnings to fall 140.00% to -10 cents per share on May 20

Unicycive Therapeutics UNCY Stock Earnings Reports
Q1'25
Est.
$-0.10
Q4'24
Beat
by $0.34
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.09
Q1'24
Missed
by $0.82
The last earnings report on March 31 showed earnings per share of 25 cents, beating the estimate of -9 cents. With 879.67K shares outstanding, the current market capitalization sits at 65.55M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAPR9.290.41
+4.62%
Capricor Therapeutics
HALO60.222.52
+4.37%
Halozyme Therapeutics
NVS107.524.12
+3.98%
Novartis AG
SRTS4.610.03
+0.66%
Sensus Healthcare
FBK40.56-0.23
-0.56%
FB Financial Corp

UNCY and Stocks

Correlation & Price change

A.I.dvisor tells us that UNCY and IRD have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UNCY and IRD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+3.54%
IRD - UNCY
33%
Poorly correlated
-6.08%
VKTX - UNCY
32%
Poorly correlated
-6.84%
BBIO - UNCY
32%
Poorly correlated
-1.73%
SCPX - UNCY
28%
Poorly correlated
-2.17%
NKTR - UNCY
28%
Poorly correlated
-2.25%
More